Synthesis of highly potent and selective hetaryl ureas as integrin αVβ3-Receptor antagonists
摘要:
Solid-phase synthesis and SAR of integrin alpha(v)beta(3)-receptor antagonists containing a urea moiety as non-basic guanidine mimetic are described. The most potent compounds exhibited IC50 values towards alpha(v)beta(3) in the nanomolar range and high selectivity versus related integrins like alpha(11b)beta(3). For selected examples efficacy in functional cellular assays is demonstrated. (C) 2002 Elsevier Science Ltd. All rights reserved.
Synthesis of highly potent and selective hetaryl ureas as integrin αVβ3-Receptor antagonists
摘要:
Solid-phase synthesis and SAR of integrin alpha(v)beta(3)-receptor antagonists containing a urea moiety as non-basic guanidine mimetic are described. The most potent compounds exhibited IC50 values towards alpha(v)beta(3) in the nanomolar range and high selectivity versus related integrins like alpha(11b)beta(3). For selected examples efficacy in functional cellular assays is demonstrated. (C) 2002 Elsevier Science Ltd. All rights reserved.
Die Erfindung betrifft neue Verbindungen, die an Integrinrezeptoren binden, deren Herstellung, deren Verwendung als Integrin-Rezeptorantagonisten und zur Behandlung von Krankheiten, Arzneimittelzubereitungen, enthaltend diese Verbindungen sowie Arzneimittelzubereitungen enthaltend mindestens eine weitere aktive Verbindung.
Synthesis of highly potent and selective hetaryl ureas as integrin αVβ3-Receptor antagonists
Solid-phase synthesis and SAR of integrin alpha(v)beta(3)-receptor antagonists containing a urea moiety as non-basic guanidine mimetic are described. The most potent compounds exhibited IC50 values towards alpha(v)beta(3) in the nanomolar range and high selectivity versus related integrins like alpha(11b)beta(3). For selected examples efficacy in functional cellular assays is demonstrated. (C) 2002 Elsevier Science Ltd. All rights reserved.